Current opportunities to improve outcomes of COVID-19 infection prevention and course in patients with lymphoproliferative diseases (regional analysis)
Background. Impaired immune response in patients with lymphoproliferative diseases (LPD) can lead to severe COVID-19 infection and significantly affect survival by increasing the risk of death. The effectiveness of vaccines may be reduced in people with compromised immune system function. Sequential...
Saved in:
| Main Authors: | Ch. Kh. Valiakhmetova, E. I. Siraeva |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2023-05-01
|
| Series: | Онкогематология |
| Subjects: | |
| Online Access: | https://oncohematology.abvpress.ru/ongm/article/view/820 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Outcomes and Prognostic Assessment of Post-Transplant Lymphoproliferative Disorder: 20-Year Experience
by: Hira Shaikh, et al.
Published: (2025-02-01) -
Chronic lymphoproliferative diseases: survival in cohort study of 310 patients (single-center study results and literature data)
by: V. P. Pop, et al.
Published: (2015-01-01) -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS
by: Pietro Tralongo, et al.
Published: (2024-04-01) -
Metagenomic analysis of DNA viruses from posttransplant lymphoproliferative disorders
by: Vikas R. Dharnidharka, et al.
Published: (2019-03-01) -
HUMAN HERPESVIRUS 8 AND LYMPHOPROLIFERATIVE DISEASES
by: Maria Luisa Calabrò, et al.
Published: (2018-11-01)